Diagnostics Development

Our national platform for Diagnostics Development (DD) was established to facilitate the translation of new high-throughput (HTP) techniques, such as next-generation sequencing (NGS), into clinical use. The overall aim of the platform is to meet the needs from translational researchers and clinicians in healthcare and public health systems by providing service and support at the national level in order to promote and adapt the use of HTP techniques in routine diagnostics. The platform has seven Clinical Genomics facility nodes, located at all Swedish universities with medical faculties (Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala and Örebro). The nodes in Linköping, Umeå and Örebro were added in 2019 to ensure equal access to HTP technologies in the healthcare setting nationwide.

HTP technologies have a great potential to impact future set-up for clinical diagnostics, e.g. in diagnostics of cancer, inherited diseases and communicable diseases, since significantly more information can be provided by these technologies for each patient sample. Nevertheless, HTP technologies often involve complicated work-flows and specialized equipment that generate large amounts of data requiring specialized data analysis before interpretation. Thus, the clinical implementation of these techniques requires careful adaptation to healthcare requirements regarding rapid and secure handling and processing of data as well as accurate interpretation of test results.

To help healthcare and public health systems to overcome these challenges as well as to keep pace with the rapidly developing techniques, this platform integrates technological, bioinformatics and clinical expertise to facilitate the application of HTP genomics in diagnostics. An important aim for the platform is to disseminate up-to-date information about established assays/protocols and hence serve as a national competence center for HTP analysis in collaboration with hospitals and public health organizations throughout the country. A crucial aspect of this work is also to prepare national guidelines and ethical principles for interpretation of test results using these new technologies.

Platform director: Richard Rosenquist Brandell (Karolinska Institutet)

Vice platform director: Lucia Cavelier (Uppsala University)

Genomic Medicine Sweden

The Clinical Genomics facilities lay the foundation for Genomic Medicine Sweden (GMS), with the aim to give patients all over Sweden access to large-scale genomic analyses and thereby improve diagnostics and individualized treatment. The Clinical Genomics facility nodes work in close collaboration with GMS, taking part in the development of novel technologies to be implemented in routine clinical diagnostics.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Ok!Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT